[1]
S. Shinde, S. Avhad, V. Morkar, C. Patki, H. Chikhale, and L. Borse, “Overview on remogliflozin SGLT-2 inhibitor in the management of type-2 diabetic mellitus in human beings”, FEB, vol. 112, no. 4, pp. 156–167, Dec. 2023.